Literature DB >> 17467247

TRP channels and pain.

Daniel N Cortright1, James E Krause, Daniel C Broom.   

Abstract

Since the molecular identification of the capsaicin receptor, now known as TRPV1, transient receptor potential (TRP) channels have occupied an important place in the understanding of sensory nerve function in the context of pain. Several TRP channels exhibit sensitivity to substances previously known to cause pain or pain-like sensations; these include cinnamaldehyde, menthol, gingerol, and icillin. Many TRP channels also exhibit significant sensitivity to increases or decreases in temperature. Some TRP channels are sensitized in vitro by the activation of other receptors such that these channels may be activated by processes, such as inflammation that result in pain. TRP channels are suggested to be involved in processes as diverse as sensory neuron activation events, neurotransmitter release and action in the spinal cord, and release of inflammatory mediators. These functions strongly suggest that specific and selective inhibition of TRP channel activity will be of use in alleviating pain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17467247     DOI: 10.1016/j.bbadis.2007.03.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  35 in total

1.  TRPV1: a stress response protein in the central nervous system.

Authors:  Karen W Ho; Nicholas J Ward; David J Calkins
Journal:  Am J Neurodegener Dis       Date:  2012-04-01

2.  A single N-terminal cysteine in TRPV1 determines activation by pungent compounds from onion and garlic.

Authors:  Héctor Salazar; Itzel Llorente; Andrés Jara-Oseguera; Refugio García-Villegas; Mika Munari; Sharona E Gordon; León D Islas; Tamara Rosenbaum
Journal:  Nat Neurosci       Date:  2008-02-24       Impact factor: 24.884

3.  TRPA1 agonists delay gastric emptying in rats through serotonergic pathways.

Authors:  Hitoshi Doihara; Katsura Nozawa; Eri Kawabata-Shoda; Ryosuke Kojima; Toshihide Yokoyama; Hiroyuki Ito
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-07-24       Impact factor: 3.000

4.  Structure-activity relationships of 1,4-dihydropyridines that act as enhancers of the vanilloid receptor 1 (TRPV1).

Authors:  Eun Joo Roh; Jason M Keller; Zoltan Olah; Michael J Iadarola; Kenneth A Jacobson
Journal:  Bioorg Med Chem       Date:  2008-08-26       Impact factor: 3.641

5.  Molecular understanding and modern application of traditional medicines: triumphs and trials.

Authors:  Timothy W Corson; Craig M Crews
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

Review 6.  TRPV1: on the road to pain relief.

Authors:  Andrés Jara-Oseguera; Sidney A Simon; Tamara Rosenbaum
Journal:  Curr Mol Pharmacol       Date:  2008-11       Impact factor: 3.339

7.  The transient receptor potential channel TRPM8 is inhibited via the alpha 2A adrenoreceptor signaling pathway.

Authors:  Alexis Bavencoffe; Dimitra Gkika; Artem Kondratskyi; Benjamin Beck; Anne-Sophie Borowiec; Gabriel Bidaux; Jérôme Busserolles; Alain Eschalier; Yaroslav Shuba; Roman Skryma; Natalia Prevarskaya
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

8.  Thermosensitive transient receptor potential (TRP) channel agonists and their role in mechanical, thermal and nociceptive sensations as assessed using animal models.

Authors:  A H Klein; Minh Trannyguen; Christopher L Joe; Carstens M Iodi; E Carstens
Journal:  Chemosens Percept       Date:  2015-08       Impact factor: 1.833

9.  Properties of the inner pore region of TRPV1 channels revealed by block with quaternary ammoniums.

Authors:  Andrés Jara-Oseguera; Itzel Llorente; Tamara Rosenbaum; León D Islas
Journal:  J Gen Physiol       Date:  2008-11       Impact factor: 4.086

10.  Somatostatin modulates mast cell-induced responses in murine spinal neurons and satellite cells.

Authors:  Joeri Van Op den bosch; Luc Van Nassauw; Eric Van Marck; Jean-Pierre Timmermans
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-05-28       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.